Aftate Triple Antibiotic
NDC Package 70356-101-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Aftate Triple Antibiotic is a . Marketed by Sabel Med Llc, this product is identified by NDC 70356-101 and is authorized under FDA application part333B.

Identification & Billing

NDC Package Code
70356-101-33
Package Description
9.4 g in 1 TUBE
Product Code
70356-101
11-Digit Billing Format
70356010133
RxNorm Crosswalk
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
  • RxCUI: 204602 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment

Clinical Specifications

Proprietary Name
Aftate Triple Antibiotic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Sabel Med Llc
FDA Application #
part333B
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-01-2016
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70356-101). Click a package code to view its specific billing and regulatory data.

70356-101-01
28 g in 1 TUBE
70356-101-05
14 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70356-101-33 identifies a specific commercial package of 9.4 g in 1 tube of Aftate Triple Antibiotic, labeled by Sabel Med Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sabel Med Llc on May 01, 2016. The current certification is valid through December 31, 2018.

How is this Sabel Med Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70356010133. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70356-101-33
11-Digit CMS (5-4-2)
70356-0101-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.